Levofloxacin Unimed Pharma

Levofloxacin, the active ingredient in Levofloxacin Unimed Pharma, is a fluoroquinolone antibiotic presented as an ophthalmic solution for ocular use. Formulated for topical administration, the solution delivers the active compound directly to the eye surface, providing rapid antimicrobial activity. It treats bacterial eye infections such as conjunctivitis, keratitis and corneal ulcer in adult patients.

GNH USA supplies Levofloxacin Unimed Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to European GMP guidelines and provides regulatory documentation for importers.

Levofloxacin is indicated for bacterial ocular infections, acting on the pathogens that cause inflammation of the eye surface and cornea.

- Bacterial conjunctivitis: reduces bacterial load, alleviating redness, discharge and discomfort. - Keratitis: eradicates causative bacteria, promoting healing of the corneal epithelium. - Corneal ulcer: eliminates infection, supporting tissue repair and preventing perforation.

Ocular administration of levofloxacin may be associated with local and systemic adverse reactions.

Common Side Effects: - Eye irritation: transient burning or stinging on instillation. - Redness: mild conjunctival hyperemia. - Tearing: increased lacrimation. - Blurred vision: temporary visual disturbance.

Serious or Rare Side Effects: - Corneal ulcer worsening: rare progression despite therapy. - Severe allergic reaction: eyelid swelling, hives, or anaphylaxis. - Tendon rupture: extremely rare systemic effect reported with fluoroquinolones.

Before prescribing levofloxacin eye drops, clinicians should consider several safety measures.

- Allergy assessment: verify no known hypersensitivity to fluoroquinolones or ocular preservatives. - Contact lens use: advise removal of lenses before and after instillation to avoid drug adsorption. - Ocular surface disease: monitor patients with dry eye or epithelial defects closely. - Systemic fluoroquinolone therapy: avoid concurrent use to reduce cumulative toxicity risk. - Pregnancy and lactation: use only if potential benefit justifies potential risk, as safety data are limited. - Store at room temperature: keep in original container, protect from light and moisture.

Levofloxacin eye drops can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of tendon and central nervous system toxicity. - Topical corticosteroids: may mask signs of infection and delay healing.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops: may reduce tear production, enhancing ocular irritation. - Non‑steroidal anti‑inflammatory eye drops (NSAIDs): combined use may increase corneal toxicity. - Antacids or multivitamins containing aluminum/magnesium: if systemic absorption occurs, may reduce levofloxacin bioavailability.